Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RESCUE Study in liver transplant recipients with renal insufficiency
2005-000517-36Phase 3Terminated
- Sponsor
- Novartis
- Start
- Aug 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of everolimus in chronic kidney disease (CKD) and None (2 arms), sponsored by Novartis. Started Aug 2005; status: terminated.
02
Drugs
everolimus
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on 2005-000517-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000517-36.